Singapore markets closed

Valeo Pharma Inc. (VPHIF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.08000.0000 (0.00%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/10/2023
31/10/2022
31/10/2021
31/10/2020
Total revenue
27,745
53,910
27,745
13,557
7,470
Cost of revenue
21,464
40,833
21,464
9,602
6,089
Gross profit
6,281
13,077
6,281
3,955
1,381
Operating expenses
Research development
-
-
-
-
0
Selling general and administrative
24,901
29,152
24,478
15,720
5,094
Total operating expenses
25,391
30,305
25,391
16,525
5,681
Operating income or loss
-19,110
-17,228
-19,110
-12,570
-4,300
Interest expense
6,461
13,790
6,461
1,356
598
Total other income/expenses net
-1,483
-512
-1,483
-276
152
Income before tax
-26,920
-27,808
-26,920
-14,233
-4,761
Income tax expense
0
0
-1,174
0
-
Income from continuing operations
-25,746
-27,808
-25,746
-14,233
-4,761
Net income
-25,746
-27,808
-25,746
-14,233
-4,761
Net income available to common shareholders
-25,746
-27,808
-25,746
-14,233
-4,761
Basic EPS
-0.20
-0.32
-0.32
-0.20
-0.08
Diluted EPS
-0.20
-0.32
-0.32
-0.20
-0.08
Basic average shares
69,930
86,117
80,859
69,930
57,909
Diluted average shares
69,930
86,117
80,859
69,930
57,909